Forth Therapeutics

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Northern Biologics

This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.

Northsea Therapeutics

This company develops structurally engineered fatty acid drugs for patients with metabolic, inflammatory, and fibrotic diseases such as rare liver disorders.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Alevin Therapeutics

This biotechnology company develops small molecule integrin inhibitors to treat patients with life-threatening fibrotic diseases, including lung, liver and kidney conditions.